A new CSP position was established today on Covidien (COV). All prices include IB commissions.
| Criteria | Value |
|---|
| Dividend Champions Status | Challenger |
| Years of Consecutive Dividend Increases | 6 |
| Fair Value Estimate | $76.00 |
| Target Buy Price | $53.20 |
| Target Margin of Safety | 30.00% |
| Actual Buy Price | $52.50 |
| Actual Margin of Safety | 30.92% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|
| 10/24/2012 | COV | CSP Margin Used | CSP 100 COV @ 52.50 | | ($5,250.00) | |
| 10/24/2012 | COV | Initial Put Option | STO 1 Nov12 52.50 Put @ 0.49 | | | $48.94 |
Position Summary
| Cost Basis | ($5,250.00) |
| Income Generated | $48.94 |
| Percent Income Generated | 0.93% |
| Annualized Income Generated | 14.79% |
| Net Profit If Assigned | $48.94 |
| Percent Return If Assigned | 0.93% |
| Annualized Return If Assigned | 14.79% |
| Days Held to Expiration | 23 days |
